Experienced in Bursitis

Markus W. Laimer

Bern, BE, CH 
Experienced in Bursitis
Bern, BE, CH 
OverviewLocationsClinical Research

Overview

Markus Laimer practices in Bern, Switzerland. Mr. Laimer is rated as an Experienced expert by MediFind in the treatment of Bursitis. His top areas of expertise are Type 1 Diabetes (T1D), Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Leg or Foot Amputation.

His clinical research consists of co-authoring 66 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Bursitis.

Gender
Male

Locations

Bern, BE, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Diabetes in Pregnancy Project Und Mobile Health in Gestational Diabetes: An Open Label Randomized Controlled Monocentric Trial on the Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care
Diabetes in Pregnancy Project Und Mobile Health in Gestational Diabetes: An Open Label Randomized Controlled Monocentric Trial on the Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care
Enrollment Status: Completed
Publish Date: December 16, 2024
Intervention Type: Device
Study Phase: Not Applicable
SGLT-2 Inhibition Using Dapagliflozin During and After Physical Exercise - Effects on Glycemic Variability, Hormonal Regulators of Glucose Homeostasis and Ketone Body in Type 1 Diabetes - a Randomized, Placebo-controlled, Open-label, Cross-over Intervention Study
SGLT-2 Inhibition Using Dapagliflozin During and After Physical Exercise - Effects on Glycemic Variability, Hormonal Regulators of Glucose Homeostasis and Ketone Body in Type 1 Diabetes - a Randomized, Placebo-controlled, Open-label, Cross-over Intervention Study
Enrollment Status: Completed
Publish Date: August 31, 2023
Intervention Type: Drug
Study Drug: Forxiga
Study Phase: Phase 3
Pilot Study to Evaluate Glycaemic Control Using GlucoTab® With Insulin Degludec and Aspart in Hospitalized Patients With Diabetes Mellitus Type 2
Pilot Study to Evaluate Glycaemic Control Using GlucoTab® With Insulin Degludec and Aspart in Hospitalized Patients With Diabetes Mellitus Type 2
Enrollment Status: Completed
Publish Date: March 16, 2023
Intervention Type: Device, Drug
Study Phase: Phase 2/Phase 3
Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.
Short-term Effects of Dapagliflozin on Fasting and Postprandial Glucose Homeostasis in Male Type 1 Diabetes Patients.
Enrollment Status: Completed
Publish Date: March 16, 2023
Intervention Type: Drug
Study Drug: Dapagliflozin
Study Phase: Phase 4
YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: March 22, 2022
Intervention Type: Device
Canakinumab in Patients With COVID-19 and Type 2 Diabetes - CanCovDia Trial
Canakinumab in Patients With COVID-19 and Type 2 Diabetes - CanCovDia Trial
Enrollment Status: Completed
Publish Date: September 08, 2021
Intervention Type: Drug
Study Drug: Canakinumab
Study Phase: Phase 3
View 5 Less Clinical Trials

66 Total Publications

Swiss Diabetes and Technology recommendations.
Swiss Diabetes and Technology recommendations.
Journal: Swiss medical weekly
Published: October 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Laimer's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile